Toronto Stock Exchange Symbol: CYT
MONTREAL, Oct. 16 /PRNewswire-FirstCall/ - CryoCath Technologies Inc., the global leader in cardiac arrhythmia products to treat cardiovascular disease, today announced it filed against CryoCor, Inc. a patent infringement lawsuit in the United States District Court for the District of Delaware.
CryoCor makes and sells cryosurgical consoles, catheters and related hardware and software, including its Cardiac Cryoablation System. The Complaint charges CryoCor Inc. with infringement of several of CryoCath's United States patents related to console systems. CryoCath seeks injunctive relief from CryoCor.
CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.
This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.
|SOURCE CryoCath Technologies Inc.|
Copyright©2007 PR Newswire.
All rights reserved